These findings were verified in a third HNSCC cell line: CAL27 cells, where EGF treatment resulted in the phosphorylation of ERK1/2 as well as AKT and STAT3 (Supplementary Figure S7A). The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.